Australia markets closed

Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
28.60-0.10 (-0.35%)
At close: 04:00PM EDT
28.17 -0.43 (-1.50%)
After hours: 04:23PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Total revenue
181,740
240,735
243,231
138,287
87,992
Operating expenses
Research development
385,984
353,188
297,307
206,342
128,875
Selling general and administrative
93,543
90,932
122,817
80,981
52,276
Total operating expenses
481,153
445,737
421,738
287,323
181,151
Operating income or loss
-299,413
-205,002
-178,507
-149,036
-93,159
Interest expense
20,844
18,326
0
0
-
Total other income/expenses net
1,452
1,538
765
2,070
-583
Income before tax
-303,386
-206,491
-172,709
-140,846
-84,551
Income tax expense
-546
2,784
3,785
2
2
Income from continuing operations
-302,840
-209,275
-176,494
-140,848
-84,553
Net income
-296,814
-205,275
-176,063
-140,848
-84,553
Net income available to common shareholders
-296,814
-205,275
-176,063
-140,848
-84,553
Basic EPS
-1.92
-1.92
-1.67
-1.36
-0.84
Diluted EPS
-1.92
-1.92
-1.67
-1.36
-0.84
Basic average shares
106,750
106,750
105,426
103,745
100,722
Diluted average shares
106,750
106,750
105,426
103,745
100,722